Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation Study

NACompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

August 22, 2018

Primary Completion Date

February 15, 2023

Study Completion Date

February 15, 2023

Conditions
Tricuspid Valve InsufficiencyRight Heart FailureHeart Failure
Interventions
PROCEDURE

Tricuspid valve repair or replacement

Available rings used at Duke include the Tri-Ad™ Adams Tricuspid Ring by Medtronic, the TAILOR™ FLEXIBLE ANNULOPLASTY RING by St. Jude Medical/Abbott, and the Carpentier-Edwards Physio II Ring by Edwards LifeSciences. Available valves used at Duke include the Mosaic™ Mitral Orbutrator by Medtronic, the Carpentier-Edwardes PERIMOUNT Magna Mitral Ease Pericardial Bioprosthesis by Edwards LifeSciences, the On-X Mitral Valve, by CryoLife, the Carbomedics Prosthetic Heart Valve by LivaNova, and the St. Jude Medical™ Mechanical Heart Valve by St. Jude Medical/Abbott.

OTHER

Medical management of tricuspid regurgitation

The medical therapy involved includes inotropic medications and diuretic medications, which are standard of care for patients in this population.

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Collaborators (2)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

collaborator

Abbott

INDUSTRY

lead

Duke University

OTHER